Orange Book product · Generic (ANDA)
EPTIFIBATIDE
EPTIFIBATIDE
At a glance
Jun 05, 2015
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 05, 2015
11 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
EPTIFIBATIDE
Strength
75MG/100ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 091555
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of EPTIFIBATIDE
- 1998INTEGRILINBrand (NDA)
NDA 020718 · MSD SUB MERCK
- 2024EPTIFIBATIDEGeneric (ANDA)
ANDA 213599 · MEITHEAL
- 2021EPTIFIBATIDEGeneric (ANDA)
ANDA 213081 · SHUANGCHENG
- 2020EPTIFIBATIDEGeneric (ANDA)
ANDA 207864 · HYBIO
- 2019EPTIFIBATIDEGeneric (ANDA)
ANDA 204361 · USV
- 2019EPTIFIBATIDEGeneric (ANDA)
ANDA 204362 · USV
- 2019EPTIFIBATIDEGeneric (ANDA)
ANDA 209864 · SLATE RUN PHARMA
- 2018EPTIFIBATIDEGeneric (ANDA)
ANDA 208554 · BAXTER HLTHCARE CORP
- 2018EPTIFIBATIDEGeneric (ANDA)
ANDA 203258 · MYLAN LABS LTD
- 2018EPTIFIBATIDEGeneric (ANDA)
ANDA 204693 · SAGENT PHARMS INC
- 2017EPTIFIBATIDEGeneric (ANDA)
ANDA 205557 · ACCORD HLTHCARE
- 2017EPTIFIBATIDEGeneric (ANDA)
ANDA 204589 · RISING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
